Skip to main content

Find Clinical Trials

Home
Conditions
Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan

Clinical trial condition

Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan

Explore clinical trials studying Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan trial results

Completed

Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

NCT01409005

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +15 more
Locations: Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea

Seoul National University Hospital Seoul, South Korea

SMG-SNU Boramae Medical Center Seoul, South Korea

View Trial Details